ASTERDM:NSE-Aster DM Healthcare Limited (INR)

COMMON STOCK | Medical Care Facilities | NSE

Last Closing Price

INR 167.45

Change

0.00 (0.00)%

Market Cap

INR 85.05B

Volume

1.42M

Average Target Price

INR 160.00 (-4.45%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company provides primary, secondary, tertiary, and quaternary healthcare services through its 25 hospitals, 117 clinics, and 238 retail pharmacies under the Aster, Medcare, and Access brands. It has collaboration with Social Alpha. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates. Address: Tower D - Aspect Tower, Dubai, United Arab Emirates

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-30 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
APOLLOHOSP:NSE Apollo Hospitals Enterprise Li..

N/A

INR322.91B 197.46 24.93
FORTIS:NSE Fortis Healthcare Limited

N/A

INR112.90B 25.86 36.45
NH:NSE Narayana Hrudayalaya Limited

N/A

INR77.66B 39.73 57.75
HCG:NSE HealthCare Global Enterprises ..

N/A

INR18.54B N/A 22.30
MAXINDIA:NSE Max Healthcare Institute Limit..

N/A

INR18.42B 5.20 N/A
SHALBY:NSE Shalby Limited

N/A

INR11.33B 167.54 16.32
INDRAMEDCO:NSE Indraprastha Medical Corporati..

N/A

INR4.73B 46.11 20.99
LOTUSEYE:NSE Lotus Eye Hospital and Institu..

N/A

INR0.69B 30.10 79.57

ETFs Containing ASTERDM

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.92% 13% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.92% 13% F 46% F
Trailing 12 Months  
Capital Gain 6.55% 25% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.55% 25% F 49% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -8.36% N/A N/A 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.36% N/A N/A 34% F
Risk Return Profile  
Volatility (Standard Deviation) 14.27% N/A N/A 97% A+
Risk Adjusted Return -58.54% N/A N/A 18% F
Market Capitalization 85.05B 75% C 84% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 37.35 71% C- 26% F
Price/Book Ratio 2.62 38% F 26% F
Price / Cash Flow Ratio 6.95 75% C 41% F
EV/EBITDA 10.90 100% A+ 50% F
Management Effectiveness  
Return on Equity 7.10% 100% A+ 55% F
Return on Invested Capital 10.47% 75% C 70% C-
Return on Assets 3.13% 88% B+ 59% F
Debt to Equity Ratio 57.83% 57% F 25% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.01 25% F 46% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.